EPP Pricing Events
by Eva Menu

Life Sciences Forum 2017: Our Chairman’s Remarks: Michael Herepath 

Life Sciences Forum 2017: Our Chairman’s Remarks: Michael Herepath It was a privilege and a pleasure for me to moderate this year’s EPP Life Science forum, and my thanks to EPP and their partners, to our first-class presenters and to all our engaged and enthusiastic participants for making this 7th forum such a great success. This …

Read more

by Mia Pappijn

How to cure Pharma and Medical Device Pricing?

It's been well-documented for years now: healthcare costs keep rising, straining private and public budgets, poorer patients can’t get access to necessary care, while the better-off receive unnecessary treatment, and everyone complains about the lousy system and high prices, but nothing really changes. 

Read more







by Mia Pappijn

Adapting banks to a new normal environment of low interest rates

An environment where maturity transformation does not provide sustainable profits is an important challenge for banks. However, banks do have multiple levers to adapt and defend profitability and growth. Of those, both pricing and balance-sheet management are still underutilized levers that can deliver quick benefits while enabling banks to make better strategic decisions.

Read more







ABOUT OUR
FORUM PRODUCER